Amadix is a biotechnology company founded in 2010 focused on developing and commercializing innovative cutting-edge biomarkers for cancer diagnostics, reaching patients and physicians around the world, to improve survival and quality of life.
These assays are oriented to avoid the side effects and complications of invasive procedures, improving the diagnosis of different types of cancer through non-invasive tests in blood, urine or saliva.